Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)

NCT05667519 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.

NCT NCT05667519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05667519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)
Lead sponsor
LMU Klinikum
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2022
Completion date
October 31, 2027
Enrollment
324 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pacemaker complication, tricuspid regurgitation